Meeder Advisory Services, Inc. Bristol Myers Squibb CO Transaction History
Meeder Advisory Services, Inc.
- $1.6 Trillion
- Q4 2024
A detailed history of Meeder Advisory Services, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Meeder Advisory Services, Inc. holds 34,845 shares of BMY stock, worth $2.11 Million. This represents 0.12% of its overall portfolio holdings.
Number of Shares
34,845
Previous 26,981
29.15%
Holding current value
$2.11 Million
Previous $1.4 Billion
41.18%
% of portfolio
0.12%
Previous 0.09%
Shares
9 transactions
Others Institutions Holding BMY
# of Institutions
2,764Shares Held
1.57BCall Options Held
28MPut Options Held
28.7M-
Vanguard Group Inc Valley Forge, PA190MShares$11.5 Billion0.19% of portfolio
-
Black Rock Inc. New York, NY159MShares$9.59 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY96MShares$5.8 Billion0.44% of portfolio
-
State Street Corp Boston, MA95.1MShares$5.75 Billion0.22% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA60.3MShares$3.64 Billion0.65% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $128B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...